Dual-listed healthcare supplier Ebos has reported strong trading conditions during the Covid-19 pandemic and advised it has a strong balance sheet to meet challenging market conditions.
In a statement to the markets, Ebos chief executive John Cullity said since its first 2020 half-year results,
Want to read more? It's easy.
Choose your best value subscription option
Student
Exclusive FREE offer for uni students studying at a New Zealand university (valued at $499).
